Pet Supplements Wholesale in the USA

The National Animal Supplement Council, operating since 2001, is the industry's own answer to this gap — member companies follow labelling standards developed with FDA Center for Veterinary Medicine input and submit to independent random product testing. For US-market sourcing specifically, NASC membership is one of the few concrete, verifiable quality signals available; confirm it directly with any prospective US supplement manufacturer, checking against NASC's own published member directory.

NASC has been pushing for federal legislation (proposals like an Animal Health Supplement Act) to give the category a permanent legal home — formal FDA-role clarification, Good Manufacturing Practice regulations, and mandated safety labelling. This hasn't been enacted yet, so buyers should base current sourcing decisions on the regulatory landscape as it actually stands today, not on anticipated future rules.

In the absence of federal supplement-specific rules, individual US states' feed control laws provide a partial regulatory backstop, similar to how state feed control agencies enforce AAFCO-aligned pet food standards for complete diets. This creates some state-to-state variation in practical enforcement — worth being aware of if selling into multiple US states.

Ask specifically about current NASC membership status, request documentation of manufacturing quality practices (ideally cGMP-aligned even without a formal mandate), and ask what evidence — published research or internal testing — backs any specific health claim. A manufacturer's willingness to provide this documentation promptly is itself a meaningful signal, while reluctance or delay in producing basic quality records is worth treating as a caution flag rather than dismissing as routine administrative friction.

Joint/mobility and skin & coat supplements (see our dedicated guides for each) are the most established US categories with the longest published evidence history behind their core active ingredients; digestive/probiotic and calming supplements are growing categories with less standardised evidence bases — factor this into how conservatively you frame claims for each category.

Buyers building a US private label supplements range should confirm the manufacturer's NASC status and evidence documentation before formulation selection, then reference our general private label manufacturer guide for the underlying sourcing mechanics.

Even without a dedicated federal supplement category, US supplement labels still need accurate ingredient lists, net weight, and manufacturer/distributor information, following NASC's labelling guidelines where the manufacturer is a member — confirm label content is reviewed against current NASC standards specifically.

The most common mistake is assuming pet supplement regulation works like pet food regulation and skipping the extra verification this category genuinely requires — there's no AAFCO-equivalent safety net here. The second is not confirming NASC membership is current, since membership can lapse; ask for it to be verified against NASC's own published member list rather than accepting a manufacturer's claim at face value, since membership lapses are more common than buyers might assume and rarely announced proactively by the manufacturer itself.

Once a first US supplements order has cleared with quality and documentation verified, buyers typically move to a recurring cadence, which improves both pricing and production scheduling reliability — the same pattern seen across other pet food categories, though worth confirming the manufacturer's NASC-required independent testing continues on a regular schedule for the specific formulation as volume scales, rather than assuming a single initial certification covers every future production run indefinitely, since testing schedules and product formulations can both change quietly over the life of an ongoing supply relationship.

Candora Petcare works exclusively with NASC-member manufacturers for US-market supplement programmes, verifying quality documentation and evidence-appropriate claims given the limited formal regulatory framework buyers would otherwise have to navigate alone without dedicated support.